medigraphic.com

2012, Number 2

<< Back

Vet Mex 2012; 43 (2)

Prostatic carcinoma in dog. Case report

Campuzano-Granados J, Mancera-Padilla MY, Reyes-Matute A

Language: English/Spanish
References: 16
Page: 175-183
PDF size: 971.26 Kb.


ABSTRACT

Dogs and humans are the only species that with a certain degree of frequency develop naturally prostatic carcinoma. The prostatic carcinoma (PC) is a neoplasia which originates from the glandular epithelium of the prostate. In dogs, the frequency of appearance varies from 0.29 to 0.6% and there is no evidence of predisposition factors that favor its development; in humans there are a considerable number of factors that can be observed, like fat rich diets, genetics, among other causes. Four histological patterns have been described in dogs: tufting, micropapillar, cribriform and flat, being the former the most common. These tumors have a high metastatic rate, being the sites of incidence the regional lymph nodes, lungs and bones. The present case corresponds to an 11 year old Labrador dog that began with anorexia, prostration and lameness of the left pelvic member (LPM), progressive deterioration and no response to treatment; it had to be euthanized and necropsy was performed. At the macroscopic examination, the most outstanding findings were thrombosis in jugular veins, generalized lymph node enlargement and multiple mineralization zones in the muscles that surround the left pelvic member. Whereas in the prostate, multiple white yellowish well delimited nodules from 0.5 to 0.7 cm in diameter were found. Such nodules were constituted by neoplastic glandular epithelial cells. These cells were observed invading blood and lymphatic vessels of different organs, like muscles, skin, lung, liver, kidney, intestines, testicles and meninges. The final diagnosis of prostatic carcinoma was determined by the histological and ultrastructural characteristics and biological behavior.


REFERENCES

  1. MACLACHLAN NJ, KENNEDY PC. Tumors of the Genital Systems. In: MEUTEN DJ, editor. Tumors in Domestic animals. 4th ed. Iowa: Iowa State Press; 2002: 568-570.

  2. MORRIS J, DOBSON J. Genital Tract. In: Small animal oncology. Cambridge, UK: Blackwell Science, 2001:180-183.

  3. OBRADOVICH J, WALSHAW R, GOULLAUD E. The Influence of Castration on the Development of Prostatic Carcinoma in the Dog 43 Cases (1978-1985). J Vet Intern Med 1987; 1:183-187.

  4. BELL FW, KLAUSNER JS, HAYDEN DW, FEENEY DA, JOHNSTON SD. Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987). J Am Vet Med Assoc 1991; 199: 1623-1630.

  5. CORNELL KK, BOSTWICK DG, COOLEY DM, HALL G, HARVEY HJ, HENDRICK MJ et al. Clinical and pathologic aspects of spontaneous canine prostatic carcinoma: a retrospective analysis of 76 cases. Prostate 2000; 45: 173-183.

  6. WATERS DJ, HAYDEN DW, BELL FW, KLAUSNER JS, QIAN J, BOSTWICK DG. Prostatic intraepithelial neoplasia in dogs with spontaneouos prostate cancer. Prostate 1997; 30: 92-97.

  7. TESKE E, NAAN EC, VAN DIJK EM, VAN GARDEREN E, SCHALKEN JA. Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs. Mol Cell Endocrin 2002; 197: 251-255.

  8. LEROY BE, NORTHRUP N. Prostate cancer in dogs: Comparative and clinical aspects. Vet J 2009; 180: 149-162.

  9. WATERS DJ, SAKR WA, HAYDEN DW, LANG CM, MCKINNEY L, MURPHY GP et al. Workgroup 4: Spontaneous Prostate Carcinoma in Dogs and Nonhuman Primates. Prostate 1998; 36:64-67.

  10. US CANCER STATISTICS WORKING GROUP. United States Cancer Statistics: 1999-2002 Incidence and Mortality Web-based Report Version. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. [Serial online: 2005] [Cited: 2011 February 1]. Available from: http://www.cdc.gov/cancer/npcr/uscs/index.htm

  11. U.S. CANCER STATISTICS WORKING GROUP. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. [Serial online: 2010] [Cited: 2011 February 1]. Available from: http://www.cdc.gov/uscs.

  12. AMLING CL, KANE CJ, RIFFENBURGH RH, WARD JF, ROBERTS JL, LANCE RS et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 2001; 58:723-8.

  13. SHIDAIFAT F, DARADKA M, AL OMARI R. Effect of androgen ablation on prostatic cell differentiation in dogs. Endocr Res 2004; 30: 327-334.

  14. BULLOCK AD, ANDRIOLE GL. Screening for prostate cancer: prostate-specific antigen, digital rectal examination, and free, density, and age-specific derivatives. In: KANTOFF PW, CARROLL PR, D’AMICO AV, editors. Prostate Cancer: Principles and Practice. Philadelphia: Lippincott Williams and Wilkins, 2002; 196-199.

  15. ROSOL TJ, SARAH H. TANNEHILL-GREGG SH, LEROY BE, MANDL S, CONTAG CH. Animal Models of Bone Metastasis. Cancer 2003; 97:748-57.

  16. SORENMO KU, GOLDSCHMIDT MH, SHOFER FS, GOLDKAMP C, FERRACONE J. Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Vet Comp Oncol 2004; 2: 13-23.




2020     |     www.medigraphic.com